Dianthus Therapeutics, Inc.
DNTH· Nasdaq
Dianthus Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -0.08%
- Market cap
- $4.94B
- 55.93M shares
- Filings
- 655
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,036,000 | reported | |
| FY 2024 | 2024-12-31 | $6,235,000 | reported | |
| FY 2023 | 2023-12-31 | $2,826,000 | reported | |
| FY 2019 | 2019-12-31 | $0 | reported | |
| FY 2018 | 2018-12-31 | $0 | reported | |
| FY 2017 | 2017-12-31 | $0 | reported | |
| FY 2016 | 2016-12-31 | $0 | reported |
Dianthus Therapeutics, Inc. · CIK 1690585 · Engraved from SEC EDGAR
